Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-13

Clinical Trial Update: Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety, pharmacokinetics, and preliminary efficacy of asimadoline for pruritus in atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Asimadoline (asimadoline)

Snippet

Sponsor: Tioga Pharmaceuticals | Conditions: Pruritus, Atopic Dermatitis | Phase 2 | Status: COMPLETED